Trial intelligence / Profile preview

Mucinex D as Adjunct Therapy for Acute Respiratory Infection

NCT00441246Phase 4Completed

Sponsor
Adams Respiratory Therapeutics
Start
Feb 2007
Primary completion
May 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of guaifenesin + pseudoephedrine hydrochloride in Acute Respiratory Infection (ARI), sponsored by Adams Respiratory Therapeutics. Started Feb 2007; status: completed.

02

Drugs

guaifenesin + pseudoephedrine hydrochloride
03

Conditions

Acute Respiratory Infection (ARI)

Beyond the preview

Go deeper on NCT00441246.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00441246.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call